Hutchison China Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.54 USD
37.88 M USD
632.78 M USD
500.48 M
About HUTCHMED (China) Limited
Sector
Industry
CEO
Chig Fung Cheng
Website
Headquarters
Hong Kong
Founded
2000
IPO date
May 19, 2006
Identifiers
3
ISIN KYG4672N1198
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
513120
GF CSI Hong Kong Brand Name Drug Exchange Traded Fund UnitsWeight
1.67%
Market value
31.68 M
USD
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units AWeight
1.24%
Market value
7.86 M
USD
159567
Yinhua China Sec Hong Kong Stock Connect Innovative Drug EtfWeight
1.58%
Market value
6.54 M
USD
513200
E Fund CSI HK Connect Health Care Composite Exchange Traded Fund UnitsWeight
1.24%
Market value
3.94 M
USD
513780
INVESCO Great Wall CSI Hong Kong Connect Innovative Drug Exchange Traded Fund UnitsWeight
1.67%
Market value
2.57 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of HMDCF is 3.02 USD — it has decreased by −5.27% in the past 24 hours. Watch Hutchison China Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Hutchison China Ltd. stocks are traded under the ticker HMDCF.
We've gathered analysts' opinions on Hutchison China Ltd. future price: according to them, HMDCF price has a max estimate of 6.40 USD and a min estimate of 3.08 USD. Watch HMDCF chart and read a more detailed Hutchison China Ltd. stock forecast: see what analysts think of Hutchison China Ltd. and suggest that you do with its stocks.
HMDCF reached its all-time high on Jan 13, 2023 with the price of 13.72 USD, and its all-time low was 1.61 USD and was reached on Oct 11, 2022. View more price dynamics on HMDCF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
HMDCF stock is 5.56% volatile and has beta coefficient of 1.08. Track Hutchison China Ltd. stock price on the chart and check out the list of the most volatile stocks — is Hutchison China Ltd. there?
Today Hutchison China Ltd. has the market capitalization of 2.59 B, it has increased by 0.70% over the last week.
Yes, you can track Hutchison China Ltd. financials in yearly and quarterly reports right on TradingView.
Hutchison China Ltd. is going to release the next earnings report on Mar 5, 2026. Keep track of upcoming events with our Earnings Calendar.
HMDCF earnings for the last half-year are 0.52 USD per share, whereas the estimation was 0.29 USD, resulting in a 78.49% surprise. The estimated earnings for the next half-year are 0.50 USD per share. See more details about Hutchison China Ltd. earnings.
Hutchison China Ltd. revenue for the last half-year amounts to 277.70 M USD, despite the estimated figure of 330.39 M USD. In the next half-year revenue is expected to reach 307.00 M USD.
HMDCF net income for the last half-year is 451.49 M USD, while the previous report showed 11.95 M USD of net income which accounts for 3.68 K% change. Track more Hutchison China Ltd. financial stats to get the full picture.
No, HMDCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 1.81 K employees. See our rating of the largest employees — is Hutchison China Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hutchison China Ltd. EBITDA is −7.43 M USD, and current EBITDA margin is −5.18%. See more stats in Hutchison China Ltd. financial statements.
Like other stocks, HMDCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hutchison China Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hutchison China Ltd. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hutchison China Ltd. stock shows the strong sell signal. See more of Hutchison China Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.